Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
Nuo Therapeutics's gross margin for the twelve months ending Jun 30, 2026 was 64.1%. For fiscal 2025 it was 66.9%, against 77.8% the year before. The highest annual figure on record is 88.1% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 66.9% | −10.9 |
| FY2024 | Dec 31, 2024 | 77.8% | −1.5 |
| FY2023 | Dec 31, 2023 | 79.3% | −3.6 |
| FY2022 | Dec 31, 2022 | 82.9% | +61.3 |
| FY2019 | Dec 31, 2019 | 21.6% | −66.5 |
| FY2018 | Dec 31, 2018 | 88.1% | +139.4 |
| FY2017 | Dec 31, 2017 | -51.3% | −82.1 |
| FY2015 | Dec 31, 2015 | 30.8% | +18.0 |
| FY2014 | Dec 31, 2014 | 12.8% | −14.2 |
| FY2013 | Dec 31, 2013 | 26.9% | −36.0 |
| FY2012 | Dec 31, 2012 | 62.9% | +0.6 |
| FY2011 | Dec 31, 2011 | 62.4% | +3.6 |
| FY2010 | Dec 31, 2010 | 58.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 66.1% | −11.1 |
| Q1 FY2026 | Mar 31, 2026 | 65.3% | −9.8 |
| Q4 FY2025 | Dec 31, 2025 | 62.8% | −15.4 |
| Q3 FY2025 | Sep 30, 2025 | 60.6% | −12.3 |
| Q2 FY2025 | Jun 30, 2025 | 77.2% | −4.8 |
| Q1 FY2025 | Mar 31, 2025 | 75.0% | −3.4 |
| Q4 FY2024 | Dec 31, 2024 | 78.1% | −0.9 |
| Q3 FY2024 | Sep 30, 2024 | 72.9% | −3.9 |
| Q2 FY2024 | Jun 30, 2024 | 82.1% | −0.6 |
| Q1 FY2024 | Mar 31, 2024 | 78.4% | −4.5 |
| Q4 FY2023 | Dec 31, 2023 | 79.0% | −3.8 |
| Q3 FY2023 | Sep 30, 2023 | 76.8% | −6.2 |
| Q2 FY2023 | Jun 30, 2023 | 82.7% | +341.4 |
| Q1 FY2023 | Mar 31, 2023 | 82.9% | +42.9 |
| Q4 FY2022 | Dec 31, 2022 | 82.8% | +59.0 |
| Q3 FY2022 | Sep 30, 2022 | 83.0% | +56.2 |
| Q4 FY2019 | Dec 31, 2019 | -258.7% | −354.9 |
| Q3 FY2019 | Sep 30, 2019 | 40.0% | −42.7 |
| Q2 FY2019 | Jun 30, 2019 | 23.9% | −48.5 |
| Q1 FY2019 | Mar 31, 2019 | 26.8% | −42.5 |
| Q4 FY2018 | Dec 31, 2018 | 96.2% | +137.8 |
| Q3 FY2018 | Sep 30, 2018 | 82.8% | +145.5 |
| Q2 FY2018 | Jun 30, 2018 | 72.4% | +119.4 |
| Q1 FY2018 | Mar 31, 2018 | 69.4% | +125.7 |
| Q4 FY2017 | Dec 31, 2017 | -41.6% | +15.5 |
| Q3 FY2017 | Sep 30, 2017 | -62.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -47.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -56.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -57.0% | – |
See a number that looks wrong?